Literature DB >> 9315491

On life satisfaction in male erectile dysfunction.

A R Fugl-Meyer1, G Lodnert, I B Bränholm, K S Fugl-Meyer.   

Abstract

A consecutive series of 413 impotent men and 109 References rated their satisfaction with life as a whole and with seven different domains of life along a six graded scale ranging from very satisfied to very dissatisfied. In a subsample of impotent men treated with PGE1 these self-ratings were repeated applying the concept that dissatisfaction reflects an aspirations/achievement gap and successful treatment leads not only to increased sexual well-being but also to increased satisfaction with life as a whole. Regardless of the etiology of impotence pre-treatment level of sexual satisfaction was very low. In assumedly psychogenically impotent men levels of satisfaction with life as a whole, partnership and family life were also low. Using factor analytic technique satisfaction with sexual life was found to be a powerful predictor for satisfaction with life as a whole. In successfully PGE1-treated men pre-treatment decreased levels of satisfaction were significantly increased and generally normalization occurred.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9315491     DOI: 10.1038/sj.ijir.3900269

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  35 in total

1.  Measurement of male and female sexual dysfunction.

Authors:  R C Rosen
Journal:  Curr Psychiatry Rep       Date:  2001-06       Impact factor: 5.285

Review 2.  Prostatic irradiation-induced sexual dysfunction: a review and multidisciplinary guide to management in the radical radiotherapy era (Part I defining the organ at risk for sexual toxicities).

Authors:  Marigdalia K Ramirez-Fort; Marc J Rogers; Roberto Santiago; Sean S Mahase; Melissa Mendez; Yi Zheng; Xiang Kong; James A Kashanian; M Junaid Niaz; Shearwood McClelland; Xiaodong Wu; Neil H Bander; Peter Schlegel; John P Mulhall; Christopher S Lange
Journal:  Rep Pract Oncol Radiother       Date:  2020-03-19

3.  Randomized, double-blinded, placebo-controlled crossover trial of treating erectile dysfunction with sildenafil after radiotherapy and short-term androgen deprivation therapy: results of RTOG 0215.

Authors:  Deborah Watkins Bruner; Jennifer L James; Charlene J Bryan; Thomas M Pisansky; Marvin Rotman; Thomas Corbett; Joycelyn Speight; Roger Byhardt; Howard Sandler; Søren Bentzen; Lisa Kachnic; Lawrence Berk
Journal:  J Sex Med       Date:  2011-01-14       Impact factor: 3.802

4.  The ED-EQoL: the development of a new quality of life measure for patients with erectile dysfunction.

Authors:  R P MacDonagh; T Porter; D Pontin; P Ewings
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

Review 5.  Sildenafil citrate for female sexual arousal disorder: a future possibility?

Authors:  Corina Schoen; Gloria Bachmann
Journal:  Nat Rev Urol       Date:  2009-04       Impact factor: 14.432

Review 6.  Therapy of ED: PDE-5 Inhibitors.

Authors:  Ridwan Shabsigh
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

7.  Patterns of treatment with PDE5 inhibitors in the clinical practice in Italy: longitudinal data from the Erectile Dysfunction Observational Study.

Authors:  Ferdinando Fusco; Riccardo Sicuteri; Andrea Rossi; Stathis Kontodimas; Jose Maria Haro; Ciro Imbimbo; Vincenzo Mirone
Journal:  Asian J Androl       Date:  2009-08-24       Impact factor: 3.285

8.  Impact of erectile dysfunction and its subsequent treatment with sildenafil: qualitative study.

Authors:  John Tomlinson; David Wright
Journal:  BMJ       Date:  2004-03-29

9.  Patient preference and satisfaction in erectile dysfunction therapy: a comparison of the three phosphodiesterase-5 inhibitors sildenafil, vardenafil and tadalafil.

Authors:  Amr Abdel Raheem; Philip Kell
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

Review 10.  Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence.

Authors:  Antonio Martín Morales; Vincenzo Mirone; John Dean; Pierre Costa
Journal:  Clin Interv Aging       Date:  2009-12-29       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.